HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Doc-2/hDab2 expression is up-regulated in primary pancreatic cancer but reduced in metastasis.

AbstractSUMMARY:
DOC-2/hDab2 (DOC-2) has tumor suppressive functions in ovarian cancer and choriocarcinoma. In these tumors, it negatively influences mitogenic signal transduction of growth factors and blocks ras activity. Pancreatic cancer exhibits a high frequency of K-ras gene mutations; however, it is not known whether DOC-2 expression is altered in these tumors. Therefore, we investigated DOC-2 expression in 22 pancreatic adenocarcinomas and in 6 pancreatic cancer cell lines. Findings in human tumors were compared with normal controls and correlated with clinicopathological data. Additionally, the influence of K-ras on DOC-2 transcription was investigated. Northern blot and Western blot analyses both demonstrated an increase of DOC-2 mRNA and protein levels in primary pancreatic cancers in comparison with normal controls. In situ hybridization showed DOC-2 mRNA expression in the majority of cancer cells of primary tumors, as well as in chronic pancreatitis-like lesions surrounding the cancer mass. Immunohistochemistry mirrored the in situ hybridization findings. In contrast, levels of expression of DOC-2 in lymph node metastases were markedly decreased in comparison with levels in primary tumors. In addition, in 5 metastatic pancreatic cancer cell lines, DOC-2 mRNA and protein levels were low, whereas quantitative RT-PCR demonstrated relatively higher levels in a nonmetastatic pancreatic cancer cell line. In conclusion, DOC-2 is overexpressed in primary pancreatic adenocarcinoma but down-regulated in metastatic disease, suggesting a tumor suppressor function of DOC-2 in the late steps of pancreatic carcinogenesis.
AuthorsY Huang, H Friess, J Kleeff, I Esposito, Z Zhu, S Liu, S C Mok, A Zimmermann, M W Büchler
JournalLaboratory investigation; a journal of technical methods and pathology (Lab Invest) Vol. 81 Issue 6 Pg. 863-73 (Jun 2001) ISSN: 0023-6837 [Print] United States
PMID11406647 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Adaptor Proteins, Vesicular Transport
  • Apoptosis Regulatory Proteins
  • DAB2 protein, human
  • Proteins
  • RNA, Messenger
  • Tumor Suppressor Proteins
Topics
  • Adaptor Proteins, Signal Transducing
  • Adaptor Proteins, Vesicular Transport
  • Adenocarcinoma (metabolism, pathology, secondary)
  • Adult
  • Aged
  • Apoptosis Regulatory Proteins
  • Blotting, Northern
  • Blotting, Western
  • Female
  • Genes, Tumor Suppressor
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization
  • Male
  • Middle Aged
  • Pancreas (metabolism)
  • Pancreatic Neoplasms (metabolism, pathology, secondary)
  • Proteins (genetics, metabolism)
  • RNA, Messenger (metabolism)
  • Reference Values
  • Tumor Cells, Cultured
  • Tumor Suppressor Proteins
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: